Author： Rao V.K.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.19, Iss.2, 2002-02, pp. : 79-84
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antifibrinolytic agents: benefits > risks in transplantation
Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. :
Access to resources
Recommend
Oral anticoagulants: benefits exceed risks in patients with AF
Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. :
Benefits and Risks of Simvastatin in Patients with Familial Hypercholesterolaemia
By Mata P.
Drug Safety, Vol. 26, Iss. 11, 2003-01 ,pp. :
Vorapaxar's benefits exceed risks in select patients only
Reactions Weekly, Vol. 1, Iss. 1396, 2012-01 ,pp. :